A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the continued safety of the daily coadministration of
ABT-335 in combination with rosuvastatin calcium, simvastatin or atorvastatin calcium.